Interestingly, further analysis revealed that the xenograft tumor we tested in vivo (X1016) also has amplification of EGFR (unpublished data from G.Y.G, UAB Brain Tumor Core Facility) in addition to high levels of activated STAT3 and NF-κB, suggesting a probable classical genetic subtype. This evidence concerns the gene STAT3 and neoplasm.